https://digitalcommons.wustl.edu/oa_4/163/
"Improved gastrointestinal profile with diroximel fumarate is associate" by Annette Wundes, Sibyl...
BACKGROUND: Diroximel fumarate (DRF) is a novel oral fumarate approved for relapsing forms of multiple sclerosis (MS). DRF demonstrated significantly improved...